@volvoman hears the dogs barking "winner..." and asks: ... before a Big Fish comes along to swallow us! ... should it not be a "no brainer" for them??
Not necessarily. I can't mind-read the Big Fish, but one of their thoughts might be: "hmm, nice product. Hey you guys & gals in our R&D: come up with something as good or better...".
Anteris has not demonstrated that it can find a path to market before the Big Fish overtake DurAvr. Which of course they will overtake our product, given time.
I'm losing belief in the take-over/merger scenario. And going-it-alone? : never on the cards. I do not see that my interests and the managements' interest align: they're getting rich(er) now. I'm not.
I haven't bitten the bullet and sold yet: my sentiment remains 'hold'. Not that I'd recommend holding to anyone: it's just that that's what I'm doing ... for now.
P
AVR Price at posting:
$18.81 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)